Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.076 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.062 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |